Join Lymphoma Canada for an education session on The Drug Review Process in Quebec.
Universal Medicare. As Canadians, we are fortunate to have it and with it access to publicly-funded, highly specialized medication. The drug review process to gain access to these highly specialized and targeted therapies, however, is laborious at best, and confusing, and for lymphoma patients, this means that new and life-saving treatments are readily available in some, but not all, provinces.
Join Lymphoma Canada for an education session on The Drug Review Process in Quebec.
WHEN : Tuesday, January 21, 2014, registration from 6:30, presentation from 7:00-8:30pm
WHERE : The Jewish General Hospital, Room E711, Légaré entrance
Speaker : Marquis Nadeau, Pharmacist. Senior consultant, Quebec City
Marquis Nadeau, a skilled strategist and experienced pharmacist, is a senior consultant with the public relations firm NATIONAL. Mr Nadeau has a keen understanding of government and the pharmaceutical industry and has been instrumental in the decision-making process in health policy, particularly with regard to drug reimbursement by public and private insurance plans.
Session Highlights:
- Payment of medication in Canada
- Health Canada vs reimbursement
- Evaluation of new drugs (INESSS)
- Reimbursement of oncology drugs in Quebec
- Current issues in drug access
Presented in French, Q&A in French & English
Free admission and parking. (Underground parking on Bourret Street )
Registration is required. Seating is Limited.
** Please cancel your registration if you cannot attend to allow someone else to come in your place.
